CorMedix Inc. — Director's Dealing 2013

Sep 30, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2013-09-24

Reporting Person: Pfaffle Antony (Director, Interim Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-24	Common Stock, $0.001 par value per share	S	125	$0.92	Disposed	16725	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-20	Stock Option (right to buy)	$0.9	A	210000	Acquired	2023-03-22	Common Stock, $0.001 par value per share (210000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.68	2022-12-05	Common Stock, $0.001 par value per share (250000)	250000	Direct
Stock Option (right to buy)	$0.29	2022-01-06	Common Stock, $0.001 par value per share (30000)	30000	Direct
Stock Option (right to buy)	$2.1	2021-01-14	Common Stock, $0.001 par value per share (30000)	30000	Direct
Stock Option (right to buy)	$3.125	2020-03-30	Common Stock, $0.001 par value per share (20000)	20000	Direct

Footnotes

F1: The sale was effected by Dr. Pfaffle's broker without his knowledge as part of an account fee payment.

F2: These options vest based on performance milestones running through December 31, 2014.

F3: These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.

F4: The options vest in full on the first anniversary of the date of grant.

F5: These options vest on January 14, 2012.

F6: These options vest as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.